SRP-1005
SRP-1005-101
Phase 1 small_molecule active
Quick answer
SRP-1005 for Huntington's Disease is a Phase 1 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Huntington's Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active